RECENT NEWS  Oct 24  Comment 
BOSTON (TheStreet) -- This week's Biotech Stock Mailbag opens with Rockwell Medical . Stuart A. writes:a"Adam, Rockwell Medical has an FDA advisory committee meeting coming up soon. Can you talk aboutathe issues that might be raisedathere?" ...
New York Times  Oct 23  Comment 
The dialysis chain had been accused of making illegal kickbacks to doctors for patient referrals.
MedPage Today  Oct 20  Comment 
(MedPage Today) -- Two nephrologists discuss the role of dialysis in Ebola treatment.
New York Times  Oct 8  Comment 
Thomas Eric Duncan, a Liberian who is battling the virus, is also being treated with an experimental antiviral drug in a Dallas hospital.
New York Times  Oct 7  Comment 
Thomas Eric Duncan, a Liberian who is battling the virus, is also being treated with an experimental antiviral drug in a Dallas hospital.
Benzinga  Sep 25  Comment 
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of these products for patients with...  Sep 23  Comment 
WASHINGTON (dpa-AFX) - Yeast bloodstream infections, which are caused by Candida species, are a type of fungal infection, and if untreated, can result in serious medical complications. People who have a weak immune system, or are hospitalized in...
MedPage Today  Sep 6  Comment 
(MedPage Today) -- A new phosphate binder has been cleared to treat hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis, drugmaker Keryx Pharmaceuticals announced.
New York Times  Sep 6  Comment 
The drug, used to treat kidney disease complications, can increase the risk of heart disease, bone density problems and death.  Sep 5  Comment 
Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia DGAP-News: Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals Receives FDA Approval of Ferric...


Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki